Elevated levels of phosphorylated-tau are also apparent in AD and in contrast to total tau this marker of disease seems to be more specific to AD as opposed to other dementias (Vanmechelen et al. 2000; Itoh et al. 2001; Parnetti et al. 2001; Nagga et al. 2002). This evidence concerns the gene MAPT and Alzheimer disease.